» Articles » PMID: 7590422

Memory Metal Stents for Palliation of Malignant Obstruction of the Oesophagus and Cardia

Overview
Journal Gut
Specialty Gastroenterology
Date 1995 Sep 1
PMID 7590422
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Thirty patients with incurable malignant obstruction of the oesophagus and cardia were treated with self expanding oesophageal memory metal stents (Ultraflex) in a prospective study. The endoprostheses were successfully placed in all patients. Within one week after implantation dysphagia had improved in 25 of 30 patients (83%). Stent expansion was incomplete within one week after implantation in 12 of 30 patients (40%). After an average of two dilatation sessions eight of 12 stents had expanded completely. Five patients complained of retrosternal pain and three of them suffered from heartburn over several days despite acid inhibition. Major problems in the follow up period occurred in 10 of 30 patients (30%) and included late perforation (one) and tumour ingrowth/overgrowth (nine). All of these complications were treated endoscopically. Improvement of the dysphagia of the patients with tumour ingrowth/overgrowth lasted for about eight weeks (median; range: 2-38 weeks). Until November 1994 six of 30 patients were still alive with a survival time of 309 days (median; range: 103-368 days). It is concluded that oesophageal memory metal stents are easy to implant, prove effective in the palliation of malignant oesophageal obstructions, and have a low risk of severe complications. The only disadvantages are that incomplete initial stent expansion as well as tumour ingrowth/overgrowth occurred in nearly one third of the patients.

Citing Articles

Esophageal stenting.

Lowe A, Sheridan M Semin Intervent Radiol. 2011; 21(3):157-66.

PMID: 21331125 PMC: 3036223. DOI: 10.1055/s-2004-860874.


Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences.

Gockel I, Kneist W, Junginger T World J Surg. 2006; 30(2):183-90.

PMID: 16425075 DOI: 10.1007/s00268-005-7861-6.


A rare life-threatening complication of migrated nitinol self-expanding metallic stent (Ultraflex).

Ho H, Ong H Surg Endosc. 2004; 18(2):347.

PMID: 15106627 DOI: 10.1007/s00464-003-4248-3.


Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus.

Kaneko K, Ito H, Konishi K, Kurahashi T, Ito T, Katagiri A Br J Cancer. 2003; 88(1):18-24.

PMID: 12556953 PMC: 2376792. DOI: 10.1038/sj.bjc.6600684.


Insertion of self-expanding metal stents for malignant dysphagia: assessment of a simple endoscopic method.

Singhvi R, Abbasakoor F, Manson J Ann R Coll Surg Engl. 2000; 82(4):243-8.

PMID: 10932657 PMC: 2503496.


References
1.
Wagner H, Knyrim K, Bethge N, Starck E, Sommer N, Pausch J . [The palliative therapy of malignant esophageal obstruction with self-expanding metal endoprostheses]. Dtsch Med Wochenschr. 1992; 117(7):248-55. DOI: 10.1055/s-2008-1062304. View

2.
Kozarek R, Ball T, Patterson D . Metallic self-expanding stent application in the upper gastrointestinal tract: caveats and concerns. Gastrointest Endosc. 1992; 38(1):1-6. DOI: 10.1016/s0016-5107(92)70321-6. View

3.
Schaer J, Katon R, Ivancev K, Uchida B, Rosch J, Binmoeller K . Treatment of malignant esophageal obstruction with silicone-coated metallic self-expanding stents. Gastrointest Endosc. 1992; 38(1):7-11. DOI: 10.1016/s0016-5107(92)70322-8. View

4.
Neuhaus H, Hoffmann W, Dittler H, Niedermeyer H, Classen M . Implantation of self-expanding esophageal metal stents for palliation of malignant dysphagia. Endoscopy. 1992; 24(5):405-10. DOI: 10.1055/s-2007-1010508. View

5.
Sass N, Rienow J . [Nitinol stent in esophageal carcinoma]. Dtsch Med Wochenschr. 1993; 118(1-2):45. View